This company has been acquired
Societal CDMO Management
Management criteria checks 2/4
Societal CDMO's CEO is J. Enloe, appointed in Dec 2020, has a tenure of 3.33 years. total yearly compensation is $2.27M, comprised of 25.2% salary and 74.8% bonuses, including company stock and options. directly owns 0.76% of the company’s shares, worth $881.75K. The average tenure of the management team and the board of directors is 2.5 years and 3.3 years respectively.
Key information
J. Enloe
Chief executive officer
US$2.3m
Total compensation
| CEO salary percentage | 25.19% |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.8% |
| Management average tenure | 2.5yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Societal CDMO, Inc.'s (NASDAQ:SCTL) Price Is Right But Growth Is Lacking After Shares Rocket 38%
Feb 10
Is There An Opportunity With Societal CDMO, Inc.'s (NASDAQ:SCTL) 46% Undervaluation?
Feb 02Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?
Dec 23Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?
May 31Societal CDMO signs two CDMO service agreements
Oct 20Societal stock soars 20% on signing 2 manufacturing contracts
Sep 07Societal CDMO estimates to receive up to $50M on real estates' sales
Aug 16Societal CDMO, Lannett amend license and supply deal
Jul 12These 4 Measures Indicate That Societal CDMO (NASDAQ:SCTL) Is Using Debt Extensively
Apr 29Is Recro Pharma (NASDAQ:REPH) A Risky Investment?
Jan 06Would Shareholders Who Purchased Recro Pharma's (NASDAQ:REPH) Stock Year Be Happy With The Share price Today?
Feb 15
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$13m |
| Sep 30 2023 | n/a | n/a | -US$22m |
| Jun 30 2023 | n/a | n/a | -US$20m |
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | US$2m | US$572k | -US$20m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | -US$9m |
| Dec 31 2021 | US$1m | US$550k | -US$11m |
| Sep 30 2021 | n/a | n/a | -US$21m |
| Jun 30 2021 | n/a | n/a | -US$19m |
| Mar 31 2021 | n/a | n/a | -US$27m |
| Dec 31 2020 | US$1m | US$11k | -US$28m |
Compensation vs Market: J.'s total compensation ($USD2.27M) is above average for companies of similar size in the US market ($USD662.77K).
Compensation vs Earnings: J.'s compensation has increased whilst the company is unprofitable.
CEO
J. Enloe (59 yo)
3.3yrs
Tenure
US$2,271,540
Compensation
Mr. J. David Enloe, Jr., serves as President, Chief Executive Officer and Director at Societal CDMO, Inc. (formerly known as Recro Pharma, Inc.) since December 16, 2020. Mr. Enloe had been the Chief Execut...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 16.3yrs | US$219.89k | 0.22% $ 258.5k | |
| President | 3.3yrs | US$2.27m | 0.76% $ 881.8k | |
| Senior VP & CFO | 6.3yrs | US$1.42m | 0.49% $ 575.0k | |
| Senior VP & COO | 1.9yrs | no data | no data | |
| Senior VP & Chief Scientific Officer | no data | no data | no data | |
| Vice President of Sales | 2.3yrs | no data | no data | |
| Senior VP & Chief People Officer | 2.8yrs | no data | no data |
2.5yrs
Average Tenure
59yo
Average Age
Experienced Management: SCTL's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 16.3yrs | US$219.89k | 0.22% $ 258.5k | |
| President | 3.3yrs | US$2.27m | 0.76% $ 881.8k | |
| Independent Director | 16.3yrs | US$192.39k | 0.22% $ 250.8k | |
| Director | less than a year | no data | 0.60% $ 698.5k | |
| Independent Director | 15.3yrs | US$194.89k | 0.18% $ 209.0k | |
| Independent Director | 2.8yrs | US$189.89k | 0% $ 0 | |
| Independent Director | 7.1yrs | US$194.89k | 0.21% $ 239.2k | |
| Independent Director | 3.2yrs | US$192.39k | 0.15% $ 169.3k | |
| Independent Director | 1.6yrs | US$30.80k | 0.028% $ 33.0k |
3.3yrs
Average Tenure
64yo
Average Age
Experienced Board: SCTL's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/08 21:27 |
| End of Day Share Price | 2024/04/08 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Societal CDMO, Inc. is covered by 15 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Difei Yang | Aegis Capital Corporation |
| Patrick Trucchio | Berenberg |
| Jonathan Aschoff | Brean Capital |